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ABSTRACT
The objective of this case report was to demonstrate the feasibility of photodynamic therapy for the
treatment of feline superficial squamous cell carcinoma and to illustrate its approachability in veterinarian
practice.
Photodynamic therapy using topical 5-aminolaevulinic acid was applied on a superficial squamous cell
carcinoma at the nasal planum of a cat. After applying of the cream, the irradiation was performed with a
red Light Emitting Diode contrivance with a wavelength of 660 nm. 
The following day, the tumour area was erythematous and oedematous. On the second day after the
treatment a scab was formed. The response rate was encouraging as visual observation of the tumour area
revealed a removal of the malignant cells. The recovery of the normal epithelialised skin structure was
observed two months after the treatment. A follow-up period up to two years revealed no recurrence.
These promising results demonstrate that photodynamic therapy should be considered as treatment
modality for early stage superficial squamous cell carcinoma. 
SAMENVATTING
Aan de hand van deze casus tracht men de bruikbaarheid van fotodynamische behandeling voor een
oppervlakkig plaveiselcelcarcinoom bij een kat te illustreren en deze toegankelijk te maken voor de toepassing in
de diergeneeskundige praktijk.
Een plaveiselcelcarcinoom ter hoogte van de overgang van de neusspiegel en de neusrug bij een kat werd
fotodynamisch behandeld door middel van 5-aminolevulinezuurzalf in combinatie met bestraling door middel van 
een toestel met rode licht emitterende dioden, met een golflengte van 660 nm.
Daags na de fotodynamische behandeling vertoonde de behandelde zone erytheem en oedeem, de tweede dag
na de bestraling werd korstvorming vastgesteld. De uiteindelijke reactie van het weefsel op de behandeling was
gunstig; tijdens visuele observaties twee maanden na de behandeling werden geen maligne cellen meer vastgesteld 
en vond men normaal huidepitheel op de locatie van de laesie.
Er werd in de loop van de twee jaar durende follow-up periode geen recidief vastgesteld. 
Deze veelbelovende resultaten laten toe te concluderen dat fotodynamische behandeling bij oppervlakkige
plaveiselcelcarcinomen overwogen dient te worden.
INTRODUCTION
In clinical practice, feline squamous cell carci -
noma (SCC) of the skin is traditionally treated by
surgery, cryosurgery, intralesional chemotherapy
and/or radiotherapy (Lana et al. , 1997; Moore and
Ogilvie, 2001). Though the success ratios of these
treatments are relatively high, they do involve a
number of disadvantages. These forms of therapy are
costly and potentially harmful. They can leave a scar
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and hypo- or hyperpigmentation, and may have other
side effects such as pain, severe inflammation and
irritation (De Rosa and Bentley, 2000; Moore and
Ogilvie, 2001).
The search for a more acceptable treatment that is
capable of killing cancerous cells in a more selective
way has led to the development of photodynamic
therapy (PDT). PDT is a treatment modality based on
the interaction between a photosensitizer (precursor), 
light and oxygen, which causes photochemically in -
du ced selective cell death (De Rosa and Bentley,
2000; Guillen et al. , 2000; Maier et al. , 2001; Morton
et al. , 2002). The selective toxicity of PDT is based on 
the preferential uptake or retention of the photo -
sensitive agent at higher concentrations in tumor
tissue than in the surrounding normal tissue. Appli -
cation of the photosensitizer is followed by exposure
to light of a wavelength corresponding to one of the
absorption maxima of the photosensitizer. Light ab -
sorption transforms the sensitizing agent from its
ground state into an excited triplet state molecule. The 
excited triplet can undergo two types of reaction. It
can transfer its energy to oxygen directly to form
reactive singlet oxygen. Alternatively, it can transfer
its energy to intermediate molecules, which then react 
with oxygen to produce free radicals. As a result of the 
activation of reactive singlet oxygen or free radical
production, subsequent tissue damage is generated.
Without exposure of the photosensitizer to light of the 
appropriate wavelength, the photosensitizer is not
activated and so there is no effect on the tumor tissue
(Cairnduff et al. , 1994; Lucroy et al. , 2000; Lucroy et
al.  2002; Morton et al. , 2002; Peng et al., 1997; Stell et
al., 2001). This case report, which is aimed at fami -
liarizing practitioners with the use of PDT and providing 
the necessary information for eventual clinical appli -
cation, deals with recent clinical pro gress in topical PDT 
of skin cancer using 5-amino laevulinic acid (5-ALA)
and Light Emitting Diodes (LEDs). 
MATERIALS AND METHODS
A neutered male cat (domestic longhair, 18
months, 4 kg, FeLV negative and FIV negative) with
cytologically confirmed superficial SCC of the nasal
planum and the transition to the bridge of the nose,
and tumor grade T1 (Figure 1) (Owen, 1980; Hahn
and Richardson, 1995; Moore and Ogilvie, 2001) was
selected for photodynamic treatment with 5-ALA and 
LED. Macroscopically, a grade T1 tumor (Owen,
1980; Hahn and Richardson, 1995; Moore and Ogil -
vie, 2001) is characterized by a crusting lesion with
erythemic tissue beneath the crust. According to the
TNM classification system, a T1 tumor is superficial
and non-invasive (Owen, 1980; Hahn and Richard -
son, 1995; Moore and Ogilvie, 2001). Figure 2 pic -
tures the corresponding cytological appearance. The
diameter of the lesion (Figure 1) was approximately
1.2 cm. Clinical and routine blood examinations con -
firmed the good general health of the cat and no
palpable regional lymph node enlargements were
detected. Sensitization with 5-ALA cream was prece -
ded by cleaning of the SCC with sterile poly vi don-
 iodine 10% solution (iso-BETADINE; Asta Medica)
and removal of the crust. Two millimeters of Porphin
5-ALA cream 20% (Aladerm; Crawford Pharma -
ceuticals) was applied topically to the lesion and to a
2 mm margin of apparently normal skin tissue. Appli -
cation occurred by means of a cotton swab. The cream 
was applied over a period of five hours. Every 30
minutes the presence of the cream was examined and,
if necessary, more cream was applied. The cat was
anesthetized throughout the entire procedure to avoid
attempts to remove the cream by licking or rubbing
and to avoid discomfort. Sedation was done with
Medetomidine HCl 1 mg/ml (Domitor, Pfizer Animal
Health) at 0.05 mg/kg intramuscular and anesthesia
with Ketamine HCl 100 mg/ml (Anesketin, Eurovet)
at 2.5 mg/kg intramuscular. Propofol 10 mg/ml (Rapi -
novet, Schering-Plough), which served as mainte -
nance anesthesia, was administrated intravenously as
needed throughout the procedure. An insulant was
used to prevent hypothermia during anesthesia. After
removal of the photosensitizing agent, irradiation
was accomplished using a red Light Emitting Diode
contrivance (BIO-DIO preprototype; MDB-Laser
Bel gium) with a wavelength of 660 nm. LED irra -
diation at continuous mode was administered for a
period of 20 minutes at a power output of 80 mW,
resulting in a radiant exposure of 38 J/cm2. During
irradiation, the distance from light source to treatment 
area was 0.6 cm and aluminized tape was used to
protect the eyes of the cat from irradiation (Figure 3).
Immediately before irradiation, the tumor area was
exposed to the ultraviolet light of a Wood lamp,
verifying the presence of the typical red fluorescent
spectrum of protoporphyrin IX (PPIX).
RESULTS
Besides normal distress after anesthesia, no ad -
verse effects were monitored during a hospitalization
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of 48 hours following the treatment. Consequently,
no local anesthesia was administrated, though as a
precautionary measure an Elizabethan collar was
applied for 24 hours to prevent licking, rubbing and
scratching. 
The day following irradiation, the tumor area be -
came erythematous and somewhat edematous. The
cat did not attempt to lick or scratch the treated area.
Two days after the treatment, a scab developed. Res -
ponse to the therapy was assessed by visual obser -
vation of the tumor area at 1 month (Figure 4),
2 months, 6 months and 2 years post-treatment. The
second observation, at two months post-treatment,
revealed a complete response, which is defined as the
disappearance of the malignant cells (based on ma -
cro scopic observations) and the complete dis ap pear -
ance of the crusting lesion, which relates to the reco -
very of normal re-epithelialized skin structure. No
recurrence was noted up to two years post-treatment.  
DISCUSSION
In the perspective of this case, PDT using topical
5-ALA and LED can be considered as safe and effec -
tive in treating early stage SCC of the skin. The initial
response rate was encouraging, as normal tissue was
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Figure 1. The tumour area after cleaning and remo -
ving the crust, immediately before photodynamical
therapy with 5-aminolaevulinic acid and red Light
Emitting Diodes.
Figure 4. Response at the time of the first visual
observation, one month after the photodynamical
therapy with 5-aminolaevulinic acid and red Light
Emitting Diodes. The tumour is cleared from the
nasal planum, the crusting lesion has disappeared
and normal epithelia is emerging.
Figure 2. Cytological appearance of a tumour grade
T1 (Owen, 1980; Hahn and Richardson, 1995;
Moore and Ogilvie, 2001). 
Figure 3. Irradiation of the SCC using a red Light
Emitting Diode contrivance (BIO-DIO preproto -
type; MDB-Laser Belgium) with a wavelength of 660
nm. The eyes of the cat were protected from irra -
diation with aluminised tape.
spared and healing occurred very fast.  There also was
an excellent cosmetic result, thanks to the small
amount of crust formation. In accordance with some
studies (Reeds et al. , 2004) and in contradiction to
others (Peaston et al. , 1993; Frimberger et al., 1998;
Stell et al. , 2001; Touma et al., 2004), this study did
not reveal adverse effects such as local discomfort,
lack of appetite or vomiting. Thanks to the topical use
of the cream, systemic effects and generalized photo -
sensitization leading to cutaneous sensitivity, which
has been noted in cases of intravenously administered  
photosensitizing agent (Hahn et al., 1998), was ab -
sent and the cat could be exposed to sunlight within 24 
hours after the treatment (Savary et al. , 1998; Maier
et al., 2001).
Apart from the convincing outcome, several points 
should be noted. First of all it should be noted that
during the follow up period the cat was exposed to
nearly no direct sunlight as the owners live in an
apartment. As sun avoidance and protection from
sunlight are important precautionary measures to
prevent recurrence of superficial squamous cell carci -
nomas, one essential risk factor for possible recur -
rence was eliminated (Anonymous, 2003; Alam and
Ratner, 2001; Moore and Ogilvie, 2001). Se condly,
the lesion was rather superficial (T1)(Owen, 1980;
Hahn and Richardson, 1995; Moore and Ogil vie,
2001) and, as Peaston et al. (Peaston et al., 1993)
state, treatment is more effective in tumors at stage T2
and earlier. A third and final remark relates to the fact
that only one case, and hence one type of lesion, was
considered at one specific location. Consequently, the 
extrapolation of  the results to various types of
tumors, tumors located elsewhere than the nasal pla -
num, and tumors with deeper dermal involvement
(stages T2-T4) (Owen, 1980; Hahn and Richardson,
1995; Moore and Ogilvie, 2001) is only permitted
after the treatment of a large number of various
different tumors at different stages and at various
different locations in the body. 
The above mentioned points, which provide ample
material for future investigations, do not lower the
considerable value of this study, which has proved
that PDT can lead to beneficial results in the treatment 
of superficial SCC of the nasal planum in cats. 
Since this innovative procedure is a valuable alter -
native to conventional treatment (Reeds et al., 2004),
it is necessary to inform practitioners about it and to
familiarize them with the use of PDT. By drawing up
an elaborate description of the materials and methods, 
the investigators have endeavored to make the proce -
dure accessible for daily veterinarian practice, or at
least to encourage veterinarians to refer patients to
colleagues where PDT is available. 
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